O	0	8	Acoustic	Acoustic	JJ	B-NP
O	9	15	trauma	trauma	NN	I-NP
O	16	22	evokes	evoke	VBZ	B-VP
O	23	36	hyperactivity	hyperactivity	NN	B-NP
O	37	40	and	and	CC	I-NP
O	41	48	changes	change	NNS	I-NP
O	49	51	in	in	IN	B-PP
O	52	56	gene	gene	NN	B-NP
O	57	67	expression	expression	NN	I-NP
O	68	70	in	in	IN	B-PP
O	71	77	guinea	guinea	NN	B-NP
O	77	78	-	-	HYPH	B-NP
O	78	81	pig	pig	NN	I-NP
O	82	90	auditory	auditory	JJ	I-NP
B-Multi-tissue_structure	91	100	brainstem	brainstem	NN	I-NP
O	100	101	.	.	.	O

O	102	109	Hearing	Hear	VBG	B-VP
O	110	114	loss	loss	NN	B-NP
O	115	119	from	from	IN	B-PP
O	120	128	acoustic	acoustic	JJ	B-NP
O	129	135	trauma	trauma	NN	I-NP
O	136	138	is	be	VBZ	B-VP
O	139	140	a	a	DT	B-NP
O	141	145	risk	risk	NN	I-NP
O	146	152	factor	factor	NN	I-NP
O	153	156	for	for	IN	B-PP
O	157	165	tinnitus	tinnitus	NN	B-NP
O	165	166	.	.	.	O

O	167	173	Animal	Animal	NN	B-NP
O	174	180	models	model	NNS	I-NP
O	181	186	using	use	VBG	B-VP
O	187	195	acoustic	acoustic	JJ	B-NP
O	196	202	trauma	trauma	NN	I-NP
O	203	207	have	have	VBP	B-VP
O	208	220	demonstrated	demonstrate	VBN	I-VP
O	221	234	hyperactivity	hyperactivity	NN	B-NP
O	235	237	in	in	IN	B-PP
O	238	245	central	central	JJ	B-NP
O	246	254	auditory	auditory	JJ	I-NP
O	255	263	pathways	pathway	NNS	I-NP
O	263	264	,	,	,	O
O	265	270	which	which	WDT	B-NP
O	271	274	has	have	VBZ	B-VP
O	275	279	been	be	VBN	I-VP
O	280	289	suggested	suggest	VBN	I-VP
O	290	292	as	as	IN	B-PP
O	293	294	a	a	DT	B-NP
O	295	304	substrate	substrate	NN	I-NP
O	305	308	for	for	IN	B-PP
O	309	317	tinnitus	tinnitus	NN	B-NP
O	317	318	.	.	.	O

O	319	321	We	We	PRP	B-NP
O	322	326	used	use	VBD	B-VP
O	327	328	a	a	DT	B-NP
O	329	335	guinea	guinea	NN	I-NP
O	335	336	-	-	HYPH	B-NP
O	336	339	pig	pig	NN	I-NP
O	340	345	model	model	NN	I-NP
O	346	348	of	of	IN	B-PP
O	349	359	unilateral	unilateral	JJ	B-NP
O	360	368	acoustic	acoustic	JJ	I-NP
O	369	375	trauma	trauma	NN	I-NP
O	375	376	.	.	.	O

O	377	383	Within	Within	IN	B-PP
O	384	387	the	the	DT	B-NP
O	388	392	same	same	JJ	I-NP
O	393	400	animals	animal	NNS	I-NP
O	400	401	,	,	,	O
O	402	414	measurements	measurement	NNS	B-NP
O	415	417	of	of	IN	B-PP
O	418	428	peripheral	peripheral	JJ	B-NP
O	429	436	hearing	hearing	NN	I-NP
O	437	441	loss	loss	NN	I-NP
O	441	442	,	,	,	O
O	443	454	spontaneous	spontaneous	JJ	B-NP
O	455	463	activity	activity	NN	I-NP
O	464	466	of	of	IN	B-PP
O	467	473	single	single	JJ	B-NP
B-Cell	474	481	neurons	neuron	NNS	I-NP
O	482	484	in	in	IN	B-PP
O	485	488	the	the	DT	B-NP
B-Multi-tissue_structure	489	497	inferior	inferior	JJ	I-NP
I-Multi-tissue_structure	498	508	colliculus	colliculus	NN	I-NP
O	509	512	and	and	CC	I-NP
O	513	517	gene	gene	NN	I-NP
O	518	528	expression	expression	NN	I-NP
O	529	531	in	in	IN	B-PP
B-Multi-tissue_structure	532	540	cochlear	cochlear	JJ	B-NP
I-Multi-tissue_structure	541	548	nucleus	nucleus	NN	I-NP
O	549	552	and	and	CC	O
B-Multi-tissue_structure	553	561	inferior	inferior	JJ	B-NP
I-Multi-tissue_structure	562	572	colliculus	colliculus	NN	I-NP
O	573	577	were	be	VBD	B-VP
O	578	586	combined	combine	VBN	I-VP
O	586	587	,	,	,	O
O	588	595	acutely	acutely	RB	B-ADVP
O	596	599	and	and	CC	O
O	600	605	after	after	IN	B-PP
O	606	614	recovery	recovery	NN	B-NP
O	615	619	from	from	IN	B-PP
O	620	628	acoustic	acoustic	JJ	B-NP
O	629	635	trauma	trauma	NN	I-NP
O	635	636	.	.	.	O

O	637	642	Genes	Gene	NNS	B-NP
O	643	655	investigated	investigate	VBD	B-VP
O	656	663	related	relate	VBN	I-VP
O	664	666	to	to	TO	B-PP
O	667	677	inhibitory	inhibitory	JJ	B-NP
O	678	679	(	(	(	O
O	679	683	GABA	GABA	NN	B-NP
O	683	684	-	-	HYPH	B-NP
O	684	685	A	A	NN	I-NP
O	686	694	receptor	receptor	NN	I-NP
O	695	702	subunit	subunit	NN	I-NP
O	703	708	alpha	alpha	NN	I-NP
O	709	710	1	1	CD	I-NP
O	710	711	;	;	:	O
O	712	719	glycine	glycine	NN	B-NP
O	720	728	receptor	receptor	NN	I-NP
O	729	736	subunit	subunit	NN	I-NP
O	737	742	alpha	alpha	NN	I-NP
O	743	744	1	1	CD	I-NP
O	744	745	)	)	)	O
O	746	749	and	and	CC	O
O	750	760	excitatory	excitatory	JJ	B-NP
O	761	778	neurotransmission	neurotransmission	NN	I-NP
O	779	780	(	(	(	O
O	780	789	glutamate	glutamate	NN	B-NP
O	790	803	decarboxylase	decarboxylase	NN	I-NP
O	804	805	1	1	CD	I-NP
O	805	806	;	;	:	O
O	807	816	glutamate	glutamate	NN	B-NP
O	817	825	receptor	receptor	NN	I-NP
O	826	830	AMPA	AMPA	NN	I-NP
O	831	838	subunit	subunit	NN	I-NP
O	839	844	alpha	alpha	NN	I-NP
O	845	846	2	2	CD	I-NP
O	846	847	;	;	:	O
O	848	857	glutamate	glutamate	NN	B-NP
O	858	866	receptor	receptor	NN	I-NP
O	867	871	NMDA	NMDA	NN	I-NP
O	872	879	subunit	subunit	NN	I-NP
O	880	881	1	1	CD	I-NP
O	881	882	)	)	)	O
O	882	883	,	,	,	O
O	884	894	regulation	regulation	NN	B-NP
O	895	897	of	of	IN	B-PP
O	898	909	transmitter	transmitter	NN	B-NP
O	910	917	release	release	NN	I-NP
O	918	919	(	(	(	O
O	919	925	member	member	NN	B-NP
O	926	928	of	of	IN	B-PP
O	929	932	RAB	RAB	NN	B-NP
O	933	939	family	family	NN	I-NP
O	940	942	of	of	IN	B-PP
O	943	948	small	small	JJ	B-NP
O	949	955	GTPase	GTPase	NN	I-NP
O	955	956	;	;	:	O
O	957	961	RAB3	RAB3	NN	B-NP
O	962	968	GTPase	GTPase	NN	I-NP
O	969	979	activating	activate	VBG	B-VP
O	980	987	protein	protein	NN	B-NP
O	988	995	subunit	subunit	NN	I-NP
O	996	997	1	1	CD	I-NP
O	997	998	)	)	)	O
O	999	1002	and	and	CC	O
B-Cell	1003	1011	neuronal	neuronal	JJ	B-NP
O	1012	1024	excitability	excitability	NN	I-NP
O	1025	1026	(	(	(	O
O	1026	1035	potassium	potassium	NN	B-NP
O	1036	1043	channel	channel	NN	I-NP
O	1044	1053	subfamily	subfamily	NN	I-NP
O	1054	1055	K	K	NN	I-NP
O	1056	1062	member	member	NN	I-NP
O	1063	1065	15	15	CD	I-NP
O	1065	1066	)	)	)	O
O	1066	1067	.	.	.	O

O	1068	1076	Acoustic	Acoustic	JJ	B-NP
O	1077	1083	trauma	trauma	NN	I-NP
O	1084	1092	resulted	result	VBD	B-VP
O	1093	1095	in	in	IN	B-PP
O	1096	1106	unilateral	unilateral	JJ	B-NP
O	1107	1114	hearing	hearing	NN	I-NP
O	1115	1119	loss	loss	NN	I-NP
O	1120	1123	and	and	CC	I-NP
O	1124	1137	hyperactivity	hyperactivity	NN	I-NP
O	1138	1149	bilaterally	bilaterally	RB	B-ADVP
O	1150	1152	in	in	IN	B-PP
B-Multi-tissue_structure	1153	1161	inferior	inferior	JJ	B-NP
I-Multi-tissue_structure	1162	1172	colliculus	colliculus	NN	I-NP
O	1172	1173	.	.	.	O

O	1174	1181	Changes	Change	NNS	B-NP
O	1182	1184	in	in	IN	B-PP
O	1185	1195	expression	expression	NN	B-NP
O	1196	1198	of	of	IN	B-PP
O	1199	1208	different	different	JJ	B-NP
O	1209	1214	mRNAs	mRNA	NNS	I-NP
O	1215	1219	were	be	VBD	B-VP
O	1220	1228	observed	observe	VBN	I-VP
O	1229	1231	in	in	IN	B-PP
O	1232	1243	ipsilateral	ipsilateral	JJ	B-NP
B-Multi-tissue_structure	1244	1252	cochlear	cochlear	JJ	I-NP
I-Multi-tissue_structure	1253	1260	nucleus	nucleus	NN	I-NP
O	1261	1264	and	and	CC	B-PP
O	1265	1267	in	in	IN	B-PP
O	1268	1272	ipsi	ipsi	AFX	B-NP
O	1272	1273	-	-	HYPH	I-NP
O	1274	1277	and	and	CC	I-NP
O	1278	1291	contralateral	contralateral	JJ	I-NP
B-Multi-tissue_structure	1292	1300	inferior	inferior	JJ	I-NP
I-Multi-tissue_structure	1301	1311	colliculus	colliculus	NN	I-NP
O	1311	1312	,	,	,	O
O	1313	1324	immediately	immediately	RB	B-ADVP
O	1325	1330	after	after	IN	B-PP
O	1331	1339	acoustic	acoustic	JJ	B-NP
O	1340	1346	trauma	trauma	NN	I-NP
O	1346	1347	,	,	,	O
O	1348	1351	and	and	CC	O
O	1352	1357	after	after	IN	B-PP
O	1358	1359	2	2	CD	B-NP
O	1360	1363	and	and	CC	I-NP
O	1364	1365	4	4	CD	I-NP
O	1366	1371	weeks	week	NNS	I-NP
O	1371	1372	'	'	POS	B-NP
O	1373	1381	recovery	recovery	NN	I-NP
O	1381	1382	.	.	.	O

O	1383	1387	Gene	Gene	NN	B-NP
O	1388	1398	expression	expression	NN	I-NP
O	1399	1402	was	be	VBD	B-VP
O	1403	1412	generally	generally	RB	I-VP
O	1413	1420	reduced	reduce	VBN	I-VP
O	1421	1432	immediately	immediately	RB	B-ADVP
O	1433	1438	after	after	IN	B-PP
O	1439	1445	trauma	trauma	NN	B-NP
O	1445	1446	,	,	,	O
O	1447	1455	followed	follow	VBN	B-VP
O	1456	1458	by	by	IN	B-PP
O	1459	1460	a	a	DT	B-NP
O	1461	1467	return	return	NN	I-NP
O	1468	1470	to	to	TO	B-PP
O	1471	1475	near	near	IN	B-PP
O	1476	1482	normal	normal	JJ	B-NP
O	1483	1489	levels	level	NNS	I-NP
O	1490	1492	or	or	CC	O
O	1493	1497	over	over	AFX	B-NP
O	1497	1498	-	-	HYPH	I-NP
O	1498	1508	expression	expression	NN	I-NP
O	1509	1511	as	as	IN	B-PP
O	1512	1520	recovery	recovery	NN	B-NP
O	1521	1525	time	time	NN	I-NP
O	1526	1535	increased	increase	VBD	B-VP
O	1535	1536	.	.	.	O

O	1537	1546	Different	Different	JJ	B-NP
O	1547	1557	mechanisms	mechanism	NNS	I-NP
O	1558	1564	appear	appear	VBP	B-VP
O	1565	1567	to	to	TO	I-VP
O	1568	1576	underlie	underlie	VB	I-VP
O	1577	1580	the	the	DT	B-NP
O	1581	1592	spontaneous	spontaneous	JJ	I-NP
O	1593	1606	hyperactivity	hyperactivity	NN	I-NP
O	1607	1615	observed	observe	VBN	B-VP
O	1615	1616	.	.	.	O

O	1617	1622	There	There	EX	B-NP
O	1623	1625	is	be	VBZ	B-VP
O	1626	1634	evidence	evidence	NN	B-NP
O	1635	1637	of	of	IN	B-PP
O	1638	1642	down	down	RB	B-ADVP
O	1642	1643	-	-	HYPH	I-ADVP
O	1643	1653	regulation	regulation	NN	B-NP
O	1654	1656	of	of	IN	B-PP
O	1657	1662	genes	gene	NNS	B-NP
O	1663	1673	associated	associate	VBN	B-VP
O	1674	1678	with	with	IN	B-PP
B-Cell	1679	1687	neuronal	neuronal	JJ	B-NP
O	1688	1698	inhibition	inhibition	NN	I-NP
O	1699	1701	in	in	IN	B-PP
O	1702	1705	the	the	DT	B-NP
O	1706	1719	contralateral	contralateral	JJ	I-NP
B-Multi-tissue_structure	1720	1728	inferior	inferior	JJ	I-NP
I-Multi-tissue_structure	1729	1739	colliculus	colliculus	NN	I-NP
O	1739	1740	,	,	,	O
O	1741	1748	whereas	whereas	IN	O
O	1749	1751	in	in	IN	B-PP
O	1752	1763	ipsilateral	ipsilateral	JJ	B-NP
B-Multi-tissue_structure	1764	1772	cochlear	cochlear	JJ	I-NP
I-Multi-tissue_structure	1773	1780	nucleus	nucleus	NN	I-NP
O	1780	1781	,	,	,	O
O	1782	1791	competing	compete	VBG	B-NP
O	1792	1799	actions	action	NNS	I-NP
O	1800	1802	of	of	IN	B-PP
O	1803	1813	inhibitory	inhibitory	JJ	B-NP
O	1814	1817	and	and	CC	I-NP
O	1818	1828	excitatory	excitatory	JJ	I-NP
O	1829	1836	systems	system	NNS	I-NP
O	1837	1841	seem	seem	VBP	B-VP
O	1842	1844	to	to	TO	I-VP
O	1845	1849	play	play	VB	I-VP
O	1850	1851	a	a	DT	B-NP
O	1852	1857	major	major	JJ	I-NP
O	1858	1862	role	role	NN	I-NP
O	1863	1865	in	in	IN	B-PP
O	1866	1877	determining	determine	VBG	B-VP
O	1878	1885	overall	overall	JJ	B-NP
O	1886	1898	excitability	excitability	NN	I-NP
O	1898	1899	.	.	.	O

